NCT02549976 Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis Status COMPLETED Phase NA
NCT02542917 Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study Status COMPLETED Phase N/A
NCT02539368 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02538679 A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques Status COMPLETED Phase NA
NCT02538341 Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Status COMPLETED Phase PHASE2
NCT02531113 Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT02508012 Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases Status COMPLETED Phase NA
NCT02502552 Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort Status COMPLETED Phase N/A
NCT02499783 Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT02488005 The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction Status COMPLETED Phase NA
NCT02481687 The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease Status TERMINATED Phase N/A
NCT02465944 A Pilot Study of FFP104 in Subjects With Crohn's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT02453607 The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease Status UNKNOWN Phase N/A
NCT02452151 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Status UNKNOWN Phase PHASE4
NCT02451839 An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) Status COMPLETED Phase N/A
NCT02450513 Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study Status COMPLETED Phase N/A